Search - tctmd.com

Displaying 1 - 12 of 12

Sort: Relevancy | Date

News Daily News

Long-term Watchman Data Reassure: CAP and CAP2 Registries

Michael O'Riordan

December 02, 2019

News Conference News TCT 2019

Oral Anticoagulation After TAVR Doesn’t Reduce Ischemic Cerebral Lesions: AUREA

Michael O'Riordan

September 28, 2019

Presentation TCT 2019

A Randomized Trial of Short-Course Dual Antiplatelet Therapy vs. Oral Anticoagulation to Prevent Cerebral Embolism After Transcatheter Aortic Valve Implantation

Presenter: Victor Alfonso Dias

September 28, 2019

News Conference News ESC 2019

LAA Occluders, NOACs Provide Similar Outcomes in High-risk A-fib Patients: PRAGUE-17

Todd Neale

September 10, 2019

News Conference News ESC 2019

ESC 2019: Antiplatelets in Diabetes, CAD and A-fib, an ARNI in HFpEF, Staged Complete PCI, and More

Shelley Wood

August 22, 2019

News Daily News

Meta-analysis Supports Surgical LAA Occlusion During Cardiac Surgery, but Flaws Found

Todd Neale

August 16, 2019

News Conference News EuroPCR 2019

Amplatzer Amulet LAA Closure Device Reduces Stroke Through 2 Years: Global Registry

Caitlin E. Cox

May 31, 2019

News Industry News

Boston Scientific Initiates Trial Comparing Left Atrial Appendage Closure to Direct Oral Anticoagulants for Stroke Risk Reduction Post-AFib Ablation

May 22, 2019

News Daily News

PFO Compounds Ischemic Stroke Risk Among Patients With Pulmonary Embolism

Yael L. Maxwell

May 06, 2019

News Daily News

Two Pediatric Cardiac Catheters Recalled for Defective Balloons

L.A. McKeown

April 26, 2019

News Daily News

DOACs in Patients With Mitral Stenosis and A-fib: Analysis Suggests a Benefit

Todd Neale

March 12, 2019

News Daily News

Late Follow-up of PFO Closure for Stroke Raises Questions for Antiplatelet Duration

Shelley Wood

January 22, 2019

Advertisement

Long-term Watchman Data Reassure: CAP and CAP2 Registries

Oral Anticoagulation After TAVR Doesn’t Reduce Ischemic Cerebral Lesions: AUREA

A Randomized Trial of Short-Course Dual Antiplatelet Therapy vs. Oral Anticoagulation to Prevent Cerebral Embolism After Transcatheter Aortic Valve Implantation

LAA Occluders, NOACs Provide Similar Outcomes in High-risk A-fib Patients: PRAGUE-17

ESC 2019: Antiplatelets in Diabetes, CAD and A-fib, an ARNI in HFpEF, Staged Complete PCI, and More

Meta-analysis Supports Surgical LAA Occlusion During Cardiac Surgery, but Flaws Found

Amplatzer Amulet LAA Closure Device Reduces Stroke Through 2 Years: Global Registry

Boston Scientific Initiates Trial Comparing Left Atrial Appendage Closure to Direct Oral Anticoagulants for Stroke Risk Reduction Post-AFib Ablation

PFO Compounds Ischemic Stroke Risk Among Patients With Pulmonary Embolism

Two Pediatric Cardiac Catheters Recalled for Defective Balloons

DOACs in Patients With Mitral Stenosis and A-fib: Analysis Suggests a Benefit

Late Follow-up of PFO Closure for Stroke Raises Questions for Antiplatelet Duration

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content